NAVIDEA BIOPHARMACEUTICALS, INC. 4
4 · NAVIDEA BIOPHARMACEUTICALS, INC. · Filed Dec 11, 2014
Insider Transaction Report
Form 4
Regan William J.
SVP of lobal Regulatory Strate
Transactions
- Award
Common Stock
2014-12-08+20,000→ 30,000 total
Holdings
- 1,879(indirect: By 401(k))
Common Stock
Footnotes (1)
- [F1]Shares acquired pursuant to performance-based restricted stock upon achieving performance criteria.